Skip to main content
Hospital Pharmacy logoLink to Hospital Pharmacy
. 2013 Oct 22;48(9):736–743. doi: 10.1310/hpj4809-736

Gluten Content of the Top 200 Medications: Follow-Up to the Influence of Gluten on a Patient’s Medication Choices

Allison R King *; University of Kansas Drug Information Center Experiential Rotation Students, August 2012
PMCID: PMC3857120  PMID: 24421547

Celiac sprue is an autoimmune disease affecting the digestive system and occurs when gluten proteins, commonly found in wheat, barley, and rye, are not fully digested, stimulating an inflammatory process in the small intestine.1-3 Symptoms can appear at any point in life and can range from gastrointestinal upset, headache, low weight gain (weight loss), osteoporosis, depression, and infertility.1-4 Due to the variety of symptoms, celiac sprue is often underdiagnosed.1,2 Current estimates find that the disease affects 1 out of every 100 to 133 Americans.1,2,4,5

Treatment for celiac sprue includes complete avoidance of gluten in products that are ingested or come into contact with the mouth, including medications, lip balm, and Play-Doh.1-7 Ingestion of amounts as small as 30 to 50 mg may illicit an adverse event in patients.8 However, identification of gluten in products can be cumbersome. For food, per the FDA Food Act 2004, identification of wheat (along with milk, egg, fish, crustacean, shellfish, tree nuts, peanuts, and soybeans) on product labels, including flavorings, colorings, or additives contaminated with such, is required. 7 Allergen identification is not required for medications where gluten can be found within the inactive ingredients (such as starches or starch derivatives) or transferred through the manufacturing process.1 Ideally, this information would be contained in the package insert; however, inactive ingredients and manufacturing processes can change or are not fully described. Potential sources of gluten are not always recognized by health care professionals.1

Patients are therefore required to double-check the content of all their medications before ingestion, which can become quite burdensome depending on the number of medications and availability of information because one “good” resource is not available. Pharmacists are in a prime setting for consultation; however, without reliable resources for determining gluten content and adequate time, their job becomes labor intensive. Available resources include a Web site, glutenfreedrugs.com, that is maintained by a clinical pharmacist and contains a list of gluten-free medications, previous lists published by Hospital Pharmacy, and a list of nonprescription drugs published in the Nov/Dec 2011 edition of the Journal of the American Pharmacists Association.6,9 Other resources include the Celiac Disease Foundation (www.celiac.org), Celiac Sprue Association/USE Inc. (www.csaceliacs.org), and National Foundation for Celiac Awareness (www.celiaccentral.org); these Web sites do not contain a list of gluten-free medications, but they maintain education and support for patients. The National Foundation for Celiac Awareness offers a free continuing education program for pharmacists to provide them with a “reliable understanding of celiac disease and their role in dealing with gluten-intolerant patients.” 10 Other continuing education programs are available for allied health professionals, dietitians, mental health professionals, nurse practitioners, and nursing professionals for a nominal fee. These resources are available at www.celiaclearning.com.

In addition to answering patient and health care professional questions regarding the gluten content of medications, the University of Kansas Drug Information Center has updated previously published information with the gluten content of the top 200 drugs by total dollars and the top 200 drugs by total prescriptions, as published by Pharmacy Times in July 2012.11 The list was compiled by contacting manufacturers of the respective agents in August 2012 and asking if the [specific] drug was considered to be gluten-free. Manufacturers’ phone numbers were obtained from the Red Book and Facts & Comparisons.12,13 Only answers of “yes” or “no” were accepted, and all “yes” answers required written documentation unless otherwise noted. Companies that declined to participate were recorded as “no” answers. Table 1 summarizes the information found from the manufacturers, and it is a good starting place for practitioners when searching for a gluten-free medication. However, it is essential to double-check with the manufacturer regarding specific products, as inactive ingredients and manufacturing processes can change. The University of Kansas Drug Information Center is available to answer both patient and health care professional questions regarding the gluten content of medications (druginfo@ku.edu).

Acknowledgments

Portions of this article have been reproduced and updated from King A. Gluten content of the top 200 medications of 2009: A follow-up to the impact of celiac sprue on patient’s medication choices. Hosp Pharm. 2011;46(6):417-426.

References

  • 1. Celiac disease. National Digestive Diseases Information Clearinghouse (NDDIC) Web site. http://digestive.niddk.nih.gov/ddiseases/pubs/celiac. Accessed August 8, 2012.
  • 2.Chang HJ, Burke AE, Golub RM. Celiac disease. JAMA. 2011;306(14):1614. [DOI] [PubMed] [Google Scholar]
  • 3.Ryan M, Grossman S. Celiac disease. Gastroenterol Nurs. 2011;34(3):225–228 [DOI] [PubMed] [Google Scholar]
  • 4.Binder HJ. Disorders of absorption: Celiac sprue In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, eds. Harrison’s Principles of Internal Medicine. 16th ed New York: McGraw Hill; 2005:1770–1772 [Google Scholar]
  • 5.Errichiello S, Esposito O, Di Mase R, et al. Celiac disease: Predictors of compliance with a gluten-free diet in adolescents and young adults. Gastroenterology. 2011;50(1):54–60 [DOI] [PubMed] [Google Scholar]
  • 6.Plogsted S. Medications and celiac disease: Tips from a pharmacist. Pract Gastroenterol. 2007;31(1):58–64 [Google Scholar]
  • 7.Hlywiak K. Hidden sources of gluten. Pract Gastroenterol. 2008;32:27–39 [Google Scholar]
  • 8.Catassi C, Fabiani E, Iacono F, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007;85:160–166 [DOI] [PubMed] [Google Scholar]
  • 9.Mangione RA, Patel PN, Shin E, et al. Determining the gluten content of nonprescription drugs: Information for patients with celiac disease. Am Pharmacists Assoc. 2011;51(6):734–737 [DOI] [PubMed] [Google Scholar]
  • 10. Celiac disease training for pharmacists. http://www.proce.com/celiac-disease.html. Accessed August 15, 2013.
  • 11. Bartholow M. Top 200 prescription drugs of 2011. Pharmacy Times Web site. July 2011. http://www.pharmacytimes.com/publications/issue/2012/July2012/Top-200-Drugs-of-2011. Accessed July 24, 2012.
  • 12.Red Book.114th ed. New York: Thompson Healthcare; 2010 [Google Scholar]
  • 13. Facts & Comparisons. eAnswers online. http://factsandcomparisons.com/online-products.aspx.

Articles from Hospital Pharmacy are provided here courtesy of SAGE Publications

RESOURCES